L’Advisory Board, ha funzioni consultive e propositive sull’attività dei network di ricerca (Spoke) del Programma di Ricerca ed Innovazione HEAL ITALIA. Fornisce valutazioni sulle strategie, le prospettive economiche dei settori di ricerca e la valorizzazione della Ricerca. È composto da illustri scienziati:
Dominik Modest – Universitätsmedizin Berlin – Germany
Alessandro Doria – Joslin Diabetes Center – Denmark
Boris Zhivotovski – Karolinska Institute – Sweden
Guido Kroemer – Cell biologist, membro di numerose accademie scientifiche in Europa – France
Hans-Uwe Simon – Institute of Pharmacology (PKI), University of Bern – Switzerland
Klaus-Miachael Debatin – University Medical Center Ulm – Germany
Nick Barlev – Professor of Biomedicine, Nazarbayev University – Uzbekistan
Pierluigi Nicotera – Scientific Director and Chairman of the Executive Board, DZNE – Germany
Steve Tait – School of Cancer Sciences, University of Glasgow – UK
Wei Jia – Department of Pharmacology, Faculty of Medicine, The University of Hong Kong – China
Xin Lu – Director of Ludwig Institute for Cancer Research, Oxford Branch – UK
Ying Wang – Shanghai Jiao Tong University School of Medicine – China
Laurance Zitvogel – Gustave Roussy hospital – France
Maria Sibilia – Professor of Cellular and Molecular Tumorbiology, Center for Cancer Research at the Medical University of Vienna – Austria
Manuela Baccarini – University of Wien – Austria
Fu-Dong Shi – Department of Neurology, Tianjin Medical University – China